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Abstract
 .GABA transporters GATs play a critical role in the translemmal transport of GABA in neurons and glial cells. Two major brain
GATs, GAT-1 and GAT-3, are found in astrocytes in the adult brain. Astroglia demonstrate morphological and molecular changes in
response to brain injury and deafferentation. The present study was designed to determine whether the expression of GATs changes after
 .nerve deafferentation using the rat superior colliculus SC as a model. The immunoreactivity for GAT-1 and GAT-3, as well as GABA
 .and glutamic acid decarboxylase GAD -65 and GAD-67, was studied in the SC of control rats and rats with unilateral optic nerve
transections. Immunolabeling for both GAT-1 and GAT-3 was increased in the neuropil of the denervated SC as compared to that for the
SC of control rats or for the unaffected SC of experimental rats. In contrast, immunoreactivity for GABA, GAD-65 and GAD-67 was not
altered. The change in the immunolabeling of GAT-1 and GAT-3 was detectable at 1 day postlesion and became more evident between
3–30 days postlesion. At the electron microscopic level, immunoreactivity for both GAT-1 and GAT-3 in the unaffected SC was localized
to astrocytic processes, whereas GAT-1 immunolabeling was also present in synaptic terminals. In the deafferented SC, immunolabeling
for both GATs was elevated in the somata and processes of hypertrophied astrocytes as compared to that in the unaffected SC, whereas
GAT-1 labeling in neuronal profiles was largely unchanged. A substantial increase of GAT-1 and GAT-3 in astrocytes following optic
nerve transection suggests that these cells play a role in modulating GABA’s action in the deafferented SC. q 1998 Elsevier Science B.V.
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1. Introduction
The magnitude and duration of GABA’s activity are
determined by its high affinity transporters that are present
w xon neurons and glial cells 15 . The transport system
efficiently clears GABA from the synaptic cleft and sur-
w xrounding extracellular space following its release 15,41 .
There is also evidence that the same system may excrete
GABA from neurons and their terminals into the extracel-
lular environment in a Ca2q-independent, non-vesicular
w xmanner 1,2,17 . Four GABA transporters were cloned and
they are classified as GAT-1, GAT-2, GAT-3 and GAT-4
according to their different amino acid sequences and
w xpharmacological properties 4,8,12,19 . Antibodies directed
against these proteins and probes for their mRNA were
used to study their tissue distribution, and GAT-1 and
) Corresponding author. Fax: q1-714-8248549; e-mail: xyan@uci.edu.
GAT-3 have been shown to be brain specific
w x8,14,32,34,43 .
The cellular localization of GAT-1 and GAT-3 was
demonstrated in several regions of the adult and develop-
w xing brain 23,24,32,38,39,43,45 . In the adult rat neocortex
and hippocampus, immunolabeling for GAT-1 is localized
w xto axon terminals and astroglia 23,38 , whereas that for
w xGAT-3 occurs exclusively in astrocytic processes 24,38 .
Furthermore, immunoreactivity for GAT-1 is not found in
neuronal somata of the adult at the light microscopic level,
but sparse immunolabeling around the Golgi complex in
somata is detectable in electron microscopic preparations
w x38 . More recently, we showed that GAT-1 immuno-
reactivity is transiently present in the somata and dendrites
of neocortical and hippocampal interneurons in developing
w xrats 45 . The sublemmal distribution of GAT-1 in these
developing interneurons suggested that GAT-1 may be
involved in the release of GABA from these neurons, a
finding that is consistent with GABA’s proposed role as a
neurotrophic factor in early stages of cortical development
w x7,16,49 .
0006-8993r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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Disorganization andror malfunction of the GABAergic
system were found in experimental conditions as well as
neurological and psychiatric disorders, such as epilepsy
 w x.and schizophrenia e.g., 3,18,29,35–37 . Specifically, re-
cent findings in human epilepsy have shown that the
affected temporal lobe displays a reduction in glutamate-
stimulated GABA release which indicated a loss of GAT
w xfunction 10 . Since GATs play an important role in regu-
lating GABA’s action, it is of interest to determine whether
they are modified in their expression following neuronal
injury. In fact, glial cells, particularly astrocytes, display
morphological and molecular changes following brain in-
jury, including deafferentation, and some of these changes
may affect the function of neurotransmitters, such as gluta-
w xmate and GABA 28,42,44 . However, the underlying
mechanism for this glial regulation of neurotransmission is
not well understood. In the present study, the effect of
deafferentation on the expression of GAT-1 and GAT-3
 .was investigated in the rat superior colliculus SC after
unilateral optic nerve transection. The SC was chosen
 .because it: 1 displays high mRNA signal and strong
immunolabeling for both GAT-1 and GAT-3
w x  .8,14,19,24,32 , and 2 is particularly suitable for study
following deafferentation because the majority of retinal
projections to the visual layers of the contralateral SC is
affected whereas that to the ipsilateral SC is unaffected
w x13,20,22,30 . GABA and two isoforms of glutamate de-
carboxylase, GAD-65 and GAD-67, were also analyzed
with immunocytochemical methods in these same prepara-
tions. A preliminary report has been presented elsewhere
w x48 .
2. Materials and methods
2.1. Animals and surgery
Experiments were performed on male and female adult
 .albino rats Sprague–Dawley weighing 250–350 g. The
experimental animals were anesthetized with sodium
 .pentobarbital 50 mgrkg, i.p. prior to the surgery for
optic nerve transection. Briefly, the right eyeball was
separated along its temporal side from other orbital tissue
using an operating microscope and microsurgical instru-
ments. After the optic nerve was exposed, it was transected
with scissors about 1–2 mm behind the posterior pole of
the eyeball. All rats were returned to the vivarium after the
 .surgery and they were allowed to survive for 1 ns3 , 3
 .  .  .  .  .ns4 , 7 ns4 , 14 ns4 , 21 ns3 or 30 ns4
days. Two additional animals did not undergo this surgery
and they served as controls. All of the surgical procedures
were approved by the institutional animal research com-
mittee at UC Irvine.
2.2. Tissue preparation
Control rats and experimental rats at the above-indi-
cated time points were deeply anesthetized with an over-
dose of sodium pentobarbital and perfused transcardially
 .with 0.12 M phosphate buffered saline PBS, pH 7.4
followed by 4% paraformaldehyde and 0.5% glutaralde-
 .hyde in phosphate buffer PB, pH 7.4 . All brains were
removed and postfixed in the perfusion solution for 4–8 h
at 48C, and transferred to cold PBS for several hours to a
few days. The midbrain and brainstem were blocked from
these brains and the side ipsilateral to the nerve transection
was marked. The brain blocks were then sectioned coro-
nally at 30–50 mm with a vibratome, and sections through
the SC were collected alternately in tissue-culture wells in
PBS and processed for immunocytochemistry.
2.3. Immunocytochemistry
Free-floating sections containing the SC were immunos-
tained for GAT-1, GAT-3, GABA, GAD-65 or GAD-67
 .using the standard avidin–biotin complex ABC method.
Briefly, endogenous peroxidase activity was bleached with
 .a 20 min rinse in 0.05% hydrogen peroxide H O .2 2
Non-specific background staining was blocked by a 2 h
 .incubation in 5% normal horse serum NHS at room
temperature, after which the sections were incubated
overnight at 48C and with agitation in a PBS solution
containing 5% NHS, 0.3% Triton X-100 and one of the
following primary antibodies at the indicated dilution. The
antibodies directed against GAT-1 and GAT-3 were har-
w xvested from immunized rabbits 23,24 and were both
diluted at 1:10 000. The mouse GABA antiserum was
obtained from Sigma and diluted at 1:20 000. A mono-
clonal mouse antibody against GAD-65 from Boehringer
Mannheim was diluted at 1:2000, whereas the polyclonal
rabbit anti-GAD-67 serum from Chemicon was diluted at
1:5000. The specificity of these primary antibodies was
w xtested in previous studies 11,23,24,47 . For a control of
the immunostaining, the primary antibody was replaced by
PBS or NGS, and section processed in this way displayed
no specific immunolabeling. After the incubation with
primary antibodies, the sections were further incubated in
1% universal anti-IgG with 5% NHS in PBS for 1 h at
room temperature, followed by a 1 h incubation in 1%
ABC solution. The immunoreaction product was visualized
with 0.05% 3,3X-diaminobenzidine tetrahydrocloride and
0.005% H O . Three 10 min rinses with PBS were con-2 2
ducted between all incubations. The universal ABC kit was
obtained from Vector Laboratories.
2.4. Electron microscopy
Electron microscopic preparations were processed for
characterizing the ultrastructure of only GAT-1 and GAT-3
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immunoreactive profiles because GABAergic neurons and
terminals were previously studied in the deafferented SC
of rats by electron microscopy using antibodies to GAD
w xand GABA 13,30 . Pre-embedding immunocytochemistry
was used for brain sections from experimental rats that
survived for 7 and 14 days. Briefly, 50 mm-thick sections
were first immunostained for GAT-1 and GAT-3 as de-
scribed above, except that Triton X-100 was omitted to
 .  .  .Fig. 1. Photomicrographs of sections through a middle level of the superior colliculus SC from rats that survived 7 A–C and 30 D–F days after
 .  .  .  .unilateral optic nerve transections. The sections were immunostained for GABA A, D , glutamic acid decarboxylase GAD -65 B, E and GAD-67 C, F .
GABA immunoreactivity is localized to visual and non-visual layers of the SC, with a denser distribution of labeled somata and neuropil in the stratum
 .griseum superficiale SGS . GAD-65 and GAD-67 immunolabeled somata and puncta are concentrated in SGS. Note that there is no remarkable difference
 .in the staining intensity and distribution pattern of the immunoreactivities for these GABAergic markers between the contralateral Contra. and the
 .ipsilateral Ipsi. SC relative to the optic nerve lesion. The superficial layers of the SC are thinner in the contralateral side, and this reduction in thickness is
greater at 30 days than at 7 days. SO: Stratum opticum. Broken lines indicate the lower border of the SGS. Scale bars100 mm.
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preserve the ultrastructure of these sections and the incuba-
tion time with primary antibodies was 36–48 h. After
immunostaining, selected sections were post-stained with
osmium tetroxide, dehydrated with ethanol and acetone,
and flat-embedded in Epon. Thin sections were obtained
from comparable regions of the ipsi- and contralateral SC,
and were stained with uranyl acetate and lead citrate
before they were examined with a Philips CM10 transmis-
sion electron microscope.
3. Results
The distribution of immunolabeling for GABA, GAD
and GAT in the SC ipsilateral to the nerve transection
from operated animals showed the same laminar pattern as
the SC of normal rats. Therefore, the description of the
immunoreactivity in the normal rat SC will be from the
unaffected SC from operated rats. A comparison of the
immunostaining in the SC between the two sides unaf-
.fected and deafferented of the same operated rats will be
provided following the descriptions of the normal distribu-
tion pattern.
3.1. Distribution of GABA and GAD immunoreacti˝ity in
the unaffected SC
Light microscopic preparations revealed a greater con-
centration of GABA and GAD immunostaining in the
superficial layers than in the intermediate and deep layers
 .of the SC Fig. 1 . For example, numerous GABA im-
munoreactive somata were found in the stratum griseum
 .superficiale SGS , and GABA immunoreactive puncta
 .were densely packed in the stratum zonale SZ and SGS.
The pattern of immunolabeling for GAD-65 and GAD-67
in the SC was similar to that for GABA immunostaining.
However, the number of neuronal somata immunolabeled
for GAD appeared less than that for GABA Fig. 1B–C,
.E–F . Thus, immunostaining for GAD-65 and GAD-67
was greatest in the SZ and SGS, which contained densely
packed puncta and many neuronal somata. The immunore-
active somata for GABA and GADs were mostly small to
 .  .  .  .Fig. 2. Photomicrographs showing GAT-1 A, C and GAT-3 B, D immunolabeling in the SC of rats that survived for 24 h A, B and 3 days C, D after
unilateral optic nerve lesion. The pattern of immunoreactivity in the SC is similar for both GATs. The strongest neuropil labeling is found in the SGS,
 .whereas the stratum zonale SZ is lightly immunostained. No immunolabeled somata are present. A slight increase in labeling for GATs is recognizable
 .  .  .24 h after the lesion in the SGS of the contralateral Contra. SC A, B as compared to the ipsilateral Ipsi. SC, and this increase becomes more
 .substantial by 3 days survival C, D . Broken lines indicate the lower border of the SGS. SO: stratum opticum. Scale bars100 mm.
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medium in size, with only a few large somata that were
mainly localized to the border between the SGS and
 .stratum opticum SO . The shape of the immunoreactive
somata varied as shown previously for GABAergic in-
w xterneurons in the SC 13,25,27 .
3.2. Distribution of GABA and GAD immunoreacti˝ity in
the deafferented SC
The laminar distribution pattern of immunolabeling for
GABA and the two GADs in the deafferented SC was
 .  .Fig. 3. Photomicrographs showing immunolabeling for GAT-1 in the ipsilateral A and contralateral B SC from a rat that survived for 3 days after
 .unilateral optic nerve transection. Note the increased neuropil labeling in the SGS of the deafferented SC is present across its entire mediolateral extent B
SZ: stratum zonale; SGS: stratum griseum superficiale; SO: stratum opticum. Broken lines indicate the lower border of the SGS. Arrow indicates midline.
Scale bars200 mm.
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similar to that in the unaffected SC from operated animals
 .Fig. 1 . Furthermore, the intensity of immunolabeling for
these 3 markers did not show any differences between the
two SC from these rats at the light microscopic level at all
of the survival times examined in this study. However, the
superficial layers of the SC contralateral to the lesion
displayed a reduction in thickness that was evident at 7
 .days postlesion Fig. 1A–C and remained at later survival
 .times Fig. 1D–F . Therefore, the SC contralateral to the
optic nerve transection displayed a somewhat thinner band
of immunolabeling for GABA and GADs.
3.3. Distribution of GAT immunoreacti˝ity in the unaf-
fected SC
3.3.1. Light microscopy
Immunoreactivity for both GAT-1 and GAT-3 was
 .found exclusively in the neuropil Figs. 2–5 . No somata
 .  .Fig. 4. Photomicrographs showing increased immunolabeling for GAT-1 A and GAT-3 B in the deafferented SC of rats, 7 days following nerve
 .  .  .transection. Note that the superficial layers SZ, SGS of the SC are thinner in the contralateral Contra. side than the ipsilateral Ipsi. one, and the
immunolabeling for both GATs are darker in the SGS of the denervated SC than its counterpart. Broken lines indicate the lower border of the SGS. SO:
stratum opticum. Scale bars100 mm.
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were immunolabeled for either GAT-1 or GAT-3 at the
light microscopic level. Light immunolabeling for GAT-1
and GAT-3 was present in the SZ, but dense immuno-
staining was found in the SGS. Immunoreactive puncta for
GAT-1 and GAT-3 outlined unlabeled somata in the SGS
 .Figs. 4 and 5 . The SO contained a light immunoreactivity
for both GATs and it was organized in a reticular network.
The non-visual layers deep to the SO displayed moderate
immunolabeling for GAT-1 and GAT-3 in the neuropil
 .Fig. 3A and Fig. 5 .
3.3.2. Electron microscopy
At the electron microscopic level, GAT-1 immuno-
reactivity in the unaffected SC of operated rats was found
 .in both neuronal and glial profiles Fig. 6A–B . The
neuronal profiles were mainly synaptic terminals that
 .  .Fig. 5. Immunoreactivity for GAT-1 A and GAT-3 B in the rat SC, 30 days after unilateral optic nerve transection. The superficial layers of the
 .  .contralateral Contra. SC are substantially reduced in thickness as compared to those of the ipsilateral Ipsi. SC. The neuropil labeling for both GATs is
greater in the contralateral SC, but the difference in staining intensity is less pronounced than that in rats with a shorter survival time cf., Fig. 2C–D, Fig.
.3A–B and Fig. 4A–B . Broken lines indicate the lower border of the SGS. SO: stratum opticum. Scale bars100 mm.
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Fig. 6. Electron micrographs showing immunolabeling for GAT-1 in the SGS of an unaffected SC of a rat that survived for 7 days after an unilateral optic
 .  .  .nerve transection. A shows labeled thin profiles of astrocytic processes arrowheads that appose an immunonegative neuronal somata N and are found
 .  .  .in the neuropil. Many normal myelinated axons a are present. B shows GAT-1 immunoreactivity in two synaptic terminals a1 and a2 and several
 .  .  .astrocytic processes. The first terminal a1 contains synaptic vesicles and forms a symmetric synapse open arrow with an immunonegative dendrite D .
 .  .The second a2 also appears to have vesicles, but no synapses are associated with it. Note several labeled glial processes arrowheads scattered in the
neuropil and apposed to pre- and postsynaptic structures. Scale bars1 mm.
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Fig. 7. Electron micrographs showing GAT-3 immunoreactivity in the SGS of an unaffected SC from a rat that survived for 7 days after unilateral optic
 .  .  .nerve lesion. A shows labeled astrocytic processes arrowheads which appose an unlabeled soma N and extend between dendritic and axonal profiles.
 .The labeled processes are small and thin, and are commonly apposed to pre- and postsynaptic structures. B shows GAT-3 immunolabeled astrocytic
 .processes arrowheads in the neuropil that extend between dendrites and axon terminals. Several unlabeled synaptic terminals that are apposed by these
 .  .  .labeled processes contain synaptic vesicles. Normal myelinated axons a are also shown. Scale bars4 mm for A and 1 mm for B .
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formed symmetric synapses with unlabeled somata and
 .dendrites Fig. 6B . No GAT-1 labeling was detected in
the somata of SC neurons. The glial profiles with GAT-1
labeling were astrocytic processes and they were found to
be more numerous than labeled synaptic terminals in any
 .given area Fig. 6 . Most of the glial labeling appeared as
 .Fig. 8. Electron micrographs of GAT-1 immunoreactivity in the SGS of a deafferented SC, 7 days after optic nerve lesion. A shows numerous darkly
 .  . labeled astrocytic processes arrowheads throughout the neuropil and adjacent to an unlabeled neuronal soma N . Several large labeled profiles open
.  .  .arrows are swollen glial processes. B shows degenerating myelinated axons a and immunolabeled processes. The axons within the fibers are
 .disorganized or disrupted. The myelin sheath of the fibers are separated, broken and collapsed. Immunolabeled swollen astrocytic processes asterisks are
 .  .  .present between these degenerating axons, including one with a mitochondrion solid arrow . Scale bars4 mm for A and 1 mm for B .
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 .Fig. 9. Electron micrographs showing GAT-3 immunoreactivity in astrocytes in the SGS of the deafferented SC after a 7 day survival period. A shows a
 .labeled astrocytic soma outlined with arrowheads with a wide shell of perikaryal cytoplasm. The immunolabeling is mainly present in the sublemmal
 .  .regions. Some labeled processes asterisks of this cell extend into the neuropil. B shows labeled astrocytic processes, one of which is large and contains
 .mitochondria. Again, the immunolabeling is concentrated in sublemmal regions of this process. The labeled astrocytic processes arrowheads in this area
 .  .appose pre- and postsynaptic profiles of both symmetric curved arrows and asymmetric open arrow synapses. Scale bars1 mm.
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small individual profiles scattered in the neuropil Fig.
.6A–B . However, long, slender immunoreactive processes
were also found and they were apposed to or extended
 .along neuronal somata and dendritic shafts Fig. 6A . The
GAT-1 positive astrocytic processes in the neuropil often
were associated or apposed to profiles that formed
synapses. These synapses were both symmetric and asym-
 .metric types Fig. 6A–B . Immunoreactivity was also found
within the glial endfoot processes on capillaries not
.shown . GAT-1 immunolabeling of cell bodies of astro-
cytes was not observed.
The ultrastructural distribution of GAT-3 immuno-
reactivity in the unaffected SC was restricted to astrocytes,
 .especially their processes Fig. 7 . Thin astrocytic profiles
adjacent to neuronal somata displayed strong immuno-
 .reactivity for GAT-3 Fig. 7A . In the neuropil, the im-
munolabeled astrocytic profiles were small in diameter,
and many of them were elongated and associated with
unlabeled dendritic profiles, including the proximal portion
of primary dendrites. Other labeled glial processes were
adjacent to synaptic terminals, and sometimes they sur-
 .rounded both pre- and postsynaptic profiles Fig. 7B .
3.4. Distribution of GAT immunoreacti˝ity in the deaffer-
ented SC
3.4.1. Light microscopy
The immunostaining for GAT-1 and GAT-3 exhibited
substantial changes in the denervated SC at the light
microscopic level. The immunolabeling for both GATs
was increased slightly in the deafferented SC by the first
 .day after the optic nerve lesion Fig. 2A–B . This increase
in immunostaining became greater at 3 days postlesion
even though the thickness of the denervated SC was
almost the same as that of the unaffected SC at this time
 .Fig. 2C–D . This change was present across the entire
 .mediolateral extent of the SC Fig. 3 . In rats that survived
7 days, the increased immunoreactivity for GAT-1 and
GAT-3 in the visual layers of the deafferented SC was
 .remarkable Figs. 4 and 5 . Consistent with published data
w x41,46 , the thickness of the visual layers of the deaffer-
 .ented SC was noticeably less than its counterpart Fig. 4 .
The difference in immunolabeling for GAT-1 and GAT-3
between the two sides remained evident at 2–3 weeks after
the lesion. Rats with 30 days postlesion survival displayed
a heavier neuropil labeling for both GATs in the deaffer-
ented SC, though the degree of the difference in labeling
intensity between the two sides was less pronounced as
compared to those at earlier time points cf., Fig. 2C–D,
.Figs. 4 and 5 . The deafferentation-induced alteration in
the immunostaining for GAT-1 and GAT-3 was not ob-
served in the deeper layers of the deafferented SC Figs. 4
.and 5 .
3.4.2. Electron microscopy
The ultrastructural localization of GAT-1 and GAT-3
immunoreactivity in the visual layers of the deafferented
SC was obtained from operated animals that survived for 7
and 14 days. Preparations from these two time points
showed similar electron microscopic findings. In these
 .specimens, immunopositive astrocytes Fig. 8A, Fig. 9
 .and immunonegative myelinated axons Fig. 8B displayed
features that were different from those found in the unaf-
fected SC, whereas the synaptic terminals labeled for
GAT-1 were not found to be altered. Thus, the following
description will focus on the former findings.
The frequency of labeled astrocytic processes for both
 .GATs was much greater in the deafferented SC Fig. 8A .
The labeled processes in the denervated SC extended
between dendritic and axonal processes in the neuropil and
 .also surrounded neuronal somata Fig. 8A . GAT-1 and
GAT-3 immunolabeled processes were relatively larger in
size and were more numerous as compared to those in the
 .unaffected SC cf., Figs. 6–9 . Immunolabeling for GATs
was detected in cell bodies that were identified as astro-
cytes based upon their size and their lack of synapses on
 .their somata or processes Fig. 9A . It is interesting to note
that these labeled astrocytes from the deafferented SC
contained more cytoplasm than their counterparts from the
unaffected SC. The increase in the size of astrocytic
somata and the number of processes immunolabeled for
GATs indicated that astrocytes were hypertrophied. In both
astrocytic somata or processes, immunolabeling for GAT-1
and GAT-3 was mainly present in the sublemmal region
 .Fig. 8B, Fig. 9A–B .
Ultrastructural changes for immunonegative profiles in
the visual layers of the deafferented SC involved myeli-
nated axons. These fibers showed apparent demyelination,
and the axons within them were either disorganized or
totally disappeared, indicating a terminal degeneration of
retinal ganglion cell axons following optic nerve transec-
 .tion Fig. 8B . GAT-1 or GAT-3 immunolabeled astrocytic
processes were often seen between these degenerating
 .fibers Fig. 8B .
4. Discussion
The major finding of this experiment is that axotomy of
the retinal ganglion cells induces an elevated immuno-
staining of two GABA transporters, GAT-1 and GAT-3, in
astroglial cells in the deafferented SC. This change appears
to be selective for the optic recipient layers of the SC. Our
light and electron microscopic data indicate that the change
in immunolabeling for both GATs is mainly a result of the
reactive response of astrocytes and is not due to tissue
shrinkage subsequent to retinal terminal degeneration. First,
the increase in immunolabeling emerges as early as 1 day
and is already substantial by 3 days after optic nerve
lesion. At these time points, a reduction in the thickness of
the visual layers in the deafferented SC is not evident
w x22,40,46 . Second, immunolabeling for GAT-1 to synaptic
terminals was not altered in the deafferented SC at the
examined time points. Further, there were no changes in
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immunolabeling for two other GABAergic markers, GABA
and GAD, in neuronal somata and puncta in the deaffer-
w xented SC 26 . Thus, the enhanced labeling for GATs in
the neuropil results from an increase of staining in astro-
cytes. Consistent with this conclusion are the electron
microscopic data that show hypertrophied astrocytic pro-
cesses and somata in the deafferented SC. It remains to be
determined whether the glial hypertrophy is the only basis
for the increased immunolabeling, or that an increased
expression of GATs also occurs in astrocytes. In any
event, these changes in the immunolabeling for GATs in
the denervated SC would cause an increased uptake of
GABA.
Other specific glial markers were shown to be upregu-
lated in the denervated SC following optic nerve lesion or
eye enucleation. They include the major histocompatibility
 . w xcomplex MHC antigens in microglial cells 33 and glial
 . w xfibrillary acidic protein GFAP in astrocytes 22,40 . It is
interesting to note that an increase of GFAP expression
appears within 1 day after optic nerve lesion in the af-
w xfected SC 40 because at this same survival time the
elevation of GATs first appeared. These findings indicate
that terminal degeneration of retinal ganglion cell axons
may induce the increase of both GFAP and GATs in
astrocytes through similar mechanisms of neuron-glia in-
w xtercommunication and interaction 22,41,42,44 .
The finding of an increased staining of GATs in the
deafferented SC is of considerable interest in that both pre-
and postsynaptic markers of GABAergic synapses do not
demonstrate remarkable changes in the deafferented SC in
the first several weeks postlesion. For example, as shown
in the present and previous studies the immunolabeling for
GAD and GABA shows no changes in light microscopic
w xdistribution 13,26 . The binding activity for GABA-A
w xreceptor is also unchanged in the deafferented rat SC 5 .
In addition, the overall GAD immunolabeled synaptic
profiles in electron microscopic preparations are main-
tained in the deafferented SC, though a subtle change
occurs in that the population of GAD-positive presynaptic
terminals that form asymmetric synapses are increased.
However, this latter change became evident only after 6
weeks postlesion and thus it was thought to be related to
delayed neuroplastic responses of the tectal GABAergic
w xneurons 13 . Therefore, the increase in GAT expression in
astrocytes following deafferentation appears to be selective
for this GABAergic synaptic parameter and suggests that
GABA transporters are the most sensitive component of
the GABAergic system to respond to optic nerve lesion.
4.1. Functional considerations
There are no electrophysiological data available for the
functional changes of GABAergic interneurons in the deaf-
w xferented SC of the rat. However, Lyckman and Meyer 21
found that spontaneous tectal activity increased following
optic deafferentation in goldfish. In contrast, it was inter-
preted that overall neuronal activity of the deafferented SC
w xin the rat was reduced as determined by glucose use 5,9 .
Other data showed changes in some subtypes of glutamate
w xreceptors in this same experimental condition 6 . It is
possible that functionally both excitatory and inhibitory
neurons in the SC may alter their activity following deaf-
w xferentation 5,6,9 . Elevated GAT-1 and GAT-3 levels in
astrocytes may help to remove GABA more effectively
after its release from axon terminals, and thus tone down
inhibition in the deafferented SC. This affect would indi-
cate a functional reorganization of GABAergic neurons
following the loss of the retinal input that is known to be
w xexcitatory 25 . This notion is supported by the finding of
w xactivity-dependent transport of GABA in the brain 31 .
Thus, the effect on GABA neurotransmission by its trans-
porters in this experimental condition may serve as a
mechanism to counterbalance the loss of excitatory drive
to neurons within the deafferented optic recipient layers of
the SC.
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